Various cancer pathways, such as nuclear factor kappa B (NF-κB), protein kinase B (Akt)/mammalian target of rapamycin (mTOR), and Wnt/β-catenin, play crucial roles in breast cancer pathogenesis [4–6]. This evidence concerns the gene MTOR and breast cancer.